Back to Directory
Last Updated: 09/06/2026

Tresars

London
Founded 2019
Recombinant antibodies developed using display technology platforms

Tresars is a developer and manufacturer of synthetic, non-animal-derived recombinant antibodies for life science research.

Using phage, yeast, mRNA, and ribosome display technologies, the company selects and affinity-matures antibody clones against customer-specified protein targets without animal immunisation. Developed antibodies are manufactured in proprietary expression systems and supplied as multi-clonal preparations.

Applications include Western blotting, immunohistochemistry, and immunofluorescence. Custom antibody development is offered at no cost to researchers.